Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis

Dermatology Case Reports
Daniel J ZinnKenneth L McClain

Abstract

A patient with Multifocal Reticulohistiocytosis (MRH) of skin and joints failed treatment with etanercept, methotrexate, hydroxychloroquine, prednisone, bisphosphonates and hydroxyzine. Long term treatment with thalidomide led to marked improvement in joint and cutaneous manifestations.

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Archives of Dermatology
Bradley T KovachWilliam W Ginsburg
Journal of the American Academy of Dermatology
N FranckJ P Escande
The Australasian Journal of Dermatology
S HavillM Rademaker
Archives of Dermatology
D G Tanenbaum
© 2022 Meta ULC. All rights reserved